At Johns Hopkins Children’s Center, Sheela Magge, MD, is director of the Division of Pediatric Endocrinology and the Lawson Wilkins Endowed Chair of Pediatric Endocrinology.
Dr. Magge's clinical interests include all endocrine disorders in children and adolescents, particularly type 2 diabetes mellitus, pre-diabetes, obesity, congenital insulin resistance syndromes, congenital lipodystrophy and polycystic ovary syndrome. She is a clinician investigator dedicated to improving the lives of children with type 2 diabetes, obesity, and insulin resistance, as well as the cardiovascular implications of these conditions.
Dr. Magge has a master’s degree in clinical epidemiology from the University of Pennsylvania, and has performed patient-oriented research throughout her career. In 2007, she received a National Institutes of Health (NIH) K23 award for research on dyslipidemia and CV risk factors in pediatric obesity and type 2 diabetes. She is currently co-principal investigator of an NIH NICHD R01 study of cardiometabolic risk and obesity in adolescents with Down syndrome that was awarded in 2012. Magge is also a co-investigator for an NIH Bench-to-Bedside Award, Therapeutic Targets in African-American Youth with Type 2 Diabetes, that is examining ancestry-related differences in treatment response for pediatric type 2 diabetes. Additionally, she is the principal investigator of a 2018 National Institute of Diabetes and Digestive and Kidney Diseases R01 award studying cardiometabolic risk among South Asian adolescents compared with African-American and white peers.
Dr. Magge is interested in how differences in body composition can modify cardiometabolic risk. Her expertise led to her appointment in 2012 to the American Academy of Pediatrics Committee on Nutrition. She has numerous peer-reviewed publications in the areas of pediatric obesity, insulin resistance, body composition and type 2 diabetes.